Transition Bio Limited
- Company number
- 12747523
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 16 Jul 2020
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MARTIN, George Kelly | Director | 4 Jul 2024 | |
| KNOWLES, Tuomas Pertti Jonathan, Professor | Director | 1 Jun 2023 | |
| COHEN, Samuel | Director | 16 Jul 2020 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Tuomas Pertti Jonathan Knowles | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
16 Jul 2020 | 16 Jul 2020 |
| David Weitz | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
16 Jul 2020 | 16 Jul 2020 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | -£25,612,218 | £532,533 | 25 |
| 31 Dec 2024 | -£18,508,741 | £27,152 | 30 |
| 31 Dec 2023 | -£11,230,677 | £418,136 | 22 |
| 31 Dec 2022 | - | - | - |
| 31 Dec 2021 | -£1,298,717 | £397,250 | 9 |
Connections
Directors’ other companies
- KNOWLES, Tuomas Pertti Jonathan, Professor - Director at Sojourn Therapeutics Limited
- MARTIN, George Kelly - Director at Sojourn Therapeutics Limited